Search Results

Focus on... Full-length human recombinant parathyroid hormone for the treatment of osteoporosis.

• Authors : Cheng CM (AUTHOR); El-Ibiary SY (AUTHOR); Quercia RA (EDITOR)

• Source: Formulary. May2006, Vol. 41 Issue 5, p214-220. 4p.

Record details

Full-length human recombinant parathyroid hormone for the treatment of osteoporosis.

• Authors : Cheng, Christine M.; El-Ibiary, Shareen Y.

Subjects: PARATHYROID hormone; OSTEOPOROSIS in women; NPS Pharmaceuticals Inc.UNITED States

• Source: Formulary. May2006, Vol. 41 Issue 5, p214-226. 7p.

Record details

Current standards and future treatments of rheumatoid arthritis.

• Authors : Onysko, Mary (AUTHOR); Burch, jessica (AUTHOR)

Subjects: BIOTHERAPY; ENZYME inhibitors; THERAPEUTIC use of monoclonal antibodies

• Source: Formulary. Oct2012, Vol. 47 Issue 10, p359-368. 8p. 3 Charts.

Record details

Management of chronic kidney disease: An emphasis on delaying disease progression and treatment options.

• Authors : Crockell, Yvette J. (AUTHOR)

Subjects: DIABETES prevention; CARDIOVASCULAR disease prevention; HYPERTENSION

• Source: Formulary. Jun2012, Vol. 47 Issue 6, p228-CV3. 10p. 1 Diagram, 5 Charts.

Record details

Osteoporosis: A review of current recommendations and emerging treatment options.

• Authors : McBane, Sarah (AUTHOR)

Subjects: OSTEOPOROSIS diagnosis; RISK factors of fractures; OSTEONECROSIS

• Source: Formulary. Oct2011, Vol. 46 Issue 10, p432-446. 9p. 1 Diagram, 2 Charts.

Record details

Therapeutic considerations in managing multiple myeloma.

• Authors : Lee KW (AUTHOR); De Bellis D (AUTHOR)

• Source: Formulary. Jul2009, Vol. 44 Issue 7, p204-213. 10p.

Record details

Focus on... tocilizumab: a humanized anti-IL-6 receptor monoclonal antibody for the treatment of rheumatoid arthritis.

• Authors : Schlesselman LS (AUTHOR); Hussey AP (AUTHOR)

• Source: Formulary. Aug2008, Vol. 43 Issue 8, p272-279. 8p.

Record details

Tocilizumab.

• Authors : Schlesselman, Lauren S.; Hussey, Aaron P.

Subjects: RHEUMATOID arthritis treatment; UNITED States. Food & Drug Administration; DRUG approvalUNITED States

• Source: Formulary. Aug2008, Vol. 43 Issue 8, p272-279. 8p.

Record details

Current and emerging treatment options for postmenopausal osteoporosis.

• Authors : Maxwell AE (AUTHOR); Maclayton D (AUTHOR); Nguyen H (AUTHOR)

• Source: Formulary. May2008, Vol. 43 Issue 5, p166-174. 7p.

Record details

Update on the treatment of osteoporosis.

• Authors : Hisel, Tina M.; Phillips, Beth Bryles

Subjects: OSTEOPOROSIS treatment; PHARMACOLOGY

• Source: Formulary; Apr2003, Vol. 38 Issue 4, p223, 12p

Record details